CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
108392-00-3 | Hexadecanamide,N-[(1R,2S)-1-[(b-D-galactopyranosyloxy)methyl]-2-hydroxyheptadecyl]-,rel- (9CI); Hexadecanamide,N-[1-[(b-D-galactopyranosyloxy)methyl]-2-hydroxyheptadecyl]-,(R*,S*)-(?à)-; Hexadecanamide, N-[1-[(b-D-galactopyranosyloxy)methyl]-2-hydroxyheptadecyl]-,(R*,S*)- | ![]() | C40H79NO8 | 詳情 | 供應商 | |
76298-42-5 | Heptadecanoic acid,17-[[(4-methylphenyl)sulfonyl]oxy]-; 17-Hydroxyheptadecanoicacid tosylate | ![]() | C24H40O5S | 詳情 | 供應商 | |
40165-89-7 | Heptadecanoic acid, 3-hydroxy-; 3-Hydroxyheptadecanoicacid | ![]() | C17H34O3 | 詳情 | 供應商 | |
158021-47-7 | Hexacosanamide,N-[(1S,2S,3R)-1-[(a-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-; Hexacosanamide,N-[1-[(a-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-,[1S-(1R*,2R*,3S*)]-; KRN 7000 | ![]() | C50H99NO9 | 詳情 | 供應商 | |
163661-57-2 | Hexacosanamide,N-[(1S,2S,3R)-1-[(b-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-; Hexacosanamide,N-[1-[(b-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-,[1S-(1R*,2R*,3S*)]-; AGL 583; Agelasphin 583 | ![]() | C50H99NO9 | 詳情 | 供應商 | |
40165-84-2 | Heptadecanenitrile,3-hydroxy-; 3-Hydroxyheptadecanonitrile | ![]() | C17H33NO | 詳情 | 供應商 | |
13099-34-8 | Heptadecanoic acid,17-hydroxy-; 17-Hydroxyheptadecanoicacid; w-Hydroxyheptadecanoic acid | ![]() | C17H34O3 | 詳情 | 供應商 | |
22092-38-2 | 十五烷基環(huán)氧乙烷; 十五烷基環(huán)氧乙烷; 1,2-環(huán)氧十七烷 | Oxirane, 2-pentadecyl-; Heptadecane,1,2-epoxy- (8CI); Oxirane, pentadecyl- (9CI); 1,2-Epoxyheptadecane; Epoxide 44 | ![]() | C17H34O | 詳情 | 供應商 |
102489-95-2 | Octadecanamide,N-[(1S,2R)-1-[(b-D-glucopyranosyloxy)methyl]-2-hydroxyheptadecyl]-2-hydroxy-,(2R)-; Octadecanamide,N-[1-[(b-D-glucopyranosyloxy)methyl]-2-hydroxyheptadecyl]-2-hydroxy-,[1S-[1R*(S*),2S*]]- | ![]() | C42H83NO9 | 詳情 | 供應商 | |
13032-63-8 | Octadecanamide, N-[1-[(b-D-glucopyranosyloxy)methyl]-2-hydroxyheptadecyl]-,DL-erythro- (8CI); N-STEAROYL-DL-DIHYDRO-GLUCOCEREBROSIDE; 1-O-(β-D-Glucopyranosyl)-N-octadecanoyl-DL-dihydrosphingosine | ![]() | C42H83NO8 | 詳情 | 供應商 | |
96-56-0 | N,N,N-三甲基-ω-氨基十七烷酸內鹽; N,N,N-三甲基-ω-氨基十七烷酸內鹽; | 1-Heptadecanaminium,1-carboxy-N,N,N-trimethyl-, inner salt; (1-Carboxyheptadecyl)trimethylammoniumhydroxide, inner salt (6CI,7CI); 1-Heptadecanaminium, 1-carboxy-N,N,N-trimethyl-,hydroxide, inner salt; Ammonium, (1-carboxyheptadecyl)trimethyl-, hydroxide,inner salt (8CI); Aquarex NS; C-Cetylbetaine; Octadecanoic acid, 2-amino-,trimethylbetaine | ![]() | C21H43NO2 | 詳情 | 供應商 |
114188-55-5 | Tetradecanoic acid,2,3-dihydroxyheptadecenyl ester (9CI); Phytophthorol4 | ![]() | C31H60O4 | 詳情 | 供應商 | |
160280-45-5 | Tetradecanamide,N-[(1S,2R)-1-[[(6-deoxy-a-D-galactofuranosyl)oxy]methyl]-2-hydroxyheptadecyl]-; Tetradecanamide,N-[1-[[(6-deoxy-a-D-galactofuranosyl)oxy]methyl]-2-hydroxyheptadecyl]-,[R-(R*,S*)]-; AGL 574 | ![]() | C38H75NO7 | 詳情 | 供應商 | |
148289-22-9 | Tetracosanamide,N-[(1S,2S,3R)-1-[(a-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-; Tetracosanamide,N-[1-[(a-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-,[1S-(1R*,2R*,3S*)]-; AGL 525 | ![]() | C48H95NO9 | 詳情 | 供應商 | |
148347-33-5 | Tetracosanamide,N-[(1S,2R)-1-[(a-D-galactopyranosyloxy)methyl]-2-hydroxyheptadecyl]-; Tetracosanamide,N-[1-[(a-D-galactopyranosyloxy)methyl]-2-hydroxyheptadecyl]-,[R-(R*,S*)]-; AGL 514 | ![]() | C48H95NO8 | 詳情 | 供應商 | |
160398-32-3 | Tetradecanamide,N-[(1S,2R)-1-[(a-D-glucopyranosyloxy)methyl]-2-hydroxyheptadecyl]-; Tetradecanamide,N-[1-[(a-D-glucopyranosyloxy)methyl]-2-hydroxyheptadecyl]-,[R-(R*,S*)]-; AGL 563; Agelasphin 563 | ![]() | C38H75NO8 | 詳情 | 供應商 | |
160280-44-4 | Tetradecanamide,N-[(1S,2R)-1-[[(6-deoxy-a-D-galactopyranosyl)oxy]methyl]-2-hydroxyheptadecyl]-; Tetradecanamide,N-[1-[[(6-deoxy-a-D-galactopyranosyl)oxy]methyl]-2-hydroxyheptadecyl]-,[R-(R*,S*)]-; AGL 571 | ![]() | C38H75NO7 | 詳情 | 供應商 | |
160280-47-7 | Tetradecanamide,N-[(1S,2R)-1-[(b-L-arabinopyranosyloxy)methyl]-2-hydroxyheptadecyl]-; Tetradecanamide,N-[1-[(b-L-arabinopyranosyloxy)methyl]-2-hydroxyheptadecyl]-,[R-(R*,S*)]-; AGL 577 | ![]() | C37H73NO7 | 詳情 | 供應商 | |
148289-17-2 | Tetradecanamide,N-[(1S,2R)-1-[(a-D-galactopyranosyloxy)methyl]-2-hydroxyheptadecyl]-; Tetradecanamide,N-[1-[(a-D-galactopyranosyloxy)methyl]-2-hydroxyheptadecyl]-,[R-(R*,S*)]-; AGL 517; Agelasphin 517 | ![]() | C38H75NO8 | 詳情 | 供應商 | |
160280-46-6 | Tetradecanamide,N-[(1S,2R)-1-[[(2-deoxy-a-D-lyxo-hexopyranosyl)oxy]methyl]-2-hydroxyheptadecyl]-; Tetradecanamide,N-[1-[[(2-deoxy-a-D-lyxo-hexopyranosyl)oxy]methyl]-2-hydroxyheptadecyl]-,[R-(R*,S*)]-; AGL 575 | ![]() | C38H75NO7 | 詳情 | 供應商 |